Skip to content

Evidence-based medical research on Chinese medicine based on mind-body treatment of irritable bowel syndrome

Evidence-based medical research on Chinese medicine based on mind-body treatment of irritable bowel syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000068
Enrollment
Unknown
Registered
2024-05-20
Start date
2023-11-23
Completion date
Unknown
Last updated
2024-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irritable bowel syndrome

Interventions

IBS-D acupuncture and moxibustion group:acupuncture and moxibustion
IBS-D Western medicine group:Western medicine
IBS-C acupuncture and moxibustion group:acupuncture and moxibustion
IBS-C Chinese Medicines+acupuncture group:Chinese Medicines+acupuncture
IBS-D Chinese Medicines Group:Chinese Medicines
IBS-C Chinese Medicines Group:Chinese Medicines
IBS-D Chinese Medicines+acupuncture group:Chinese Medicines+acupuncture
IBS-C Western medicine group:Western medicine

Sponsors

Jiangsu Provincial Hospital of Integrative Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Comply with the diagnostic criteria of IBS-D and IBS-C in Chinese and Western medicine; (2) PSSS score: male =10 points, female =11 points. (3) Age: 18-80 years old, gender is not limited; (4) Informed consent and voluntary participation in the study.

Exclusion criteria

Exclusion criteria: (1) Those with organic lesions of the gastrointestinal tract; (2) Those with severe cardiac, hepatic, renal, respiratory, haematological and endocrine diseases; (3) Psychiatric patients and patients with severe neurosis; (4) Pregnant or lactating women; (5) Poor adherence to medical advice, allergic to the drug; (6) The last 3 months, the patient has not been able to take the drug. (6) Patients who have participated in clinical studies of other drugs within the past 3 months or are participating in clinical studies of other drugs. (7) Alcohol and drug abusers and drug addicts*. (8) Patients who have taken antibiotics or probiotic preparations or gastrointestinal stimulants within 1 month prior to inclusion in the trial. *Alcoholism: men consumed more than 50 grams of alcohol per day and women consumed more than 30 grams of alcohol per day; Drug use was determined by clinical symptoms.

Design outcomes

Primary

MeasureTime frame
Overall Clinical Efficacy Rating;

Secondary

MeasureTime frame
Psychological assessmen;Assessment of symptom severity;Grading of Chinese Medicine Symptoms;Quality of life assessment;

Countries

China

Contacts

Public ContactLihui

Jiangsu Provincial Hospital of Integrative Medicine

32260890@qq.com+86 176 0155 8686

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026